Number and Frequency of Albuminuria Measurements in Clinical Trials in Diabetic Nephropathy
Author(s) -
Tobias F. Kröpelin,
Dick de Zeeuw,
Dennis L. Andress,
Maarten J. Bijlsma,
Frederik Persson,
HansHenrik Parving,
Hiddo J.L. Heerspink
Publication year - 2015
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.07780814
Subject(s) - albuminuria , medicine , urology , diabetic nephropathy , type 2 diabetes , diabetes mellitus , urine , endocrinology , renal function
Albuminuria change is often used to assess drug efficacy in intervention trials in nephrology. The change is often calculated using a variable number of urine samples collected at baseline and end of treatment. Yet more albuminuria measurements usually occur. Because albuminuria shows a large day-to-day variability, this study assessed to what extent the average and the precision of the antialbuminuric drug effect varies with the number of urine collections at each visit and the number of follow-up visits.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom